Actavis buying Warner Chilcott in $8.5B deal
Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.
Business
May 20, 2013
0
0
Page 2 - News tagged with novartis
Related topics:
food and drug administration
Continuous drug manufacturing offers speed, lower costs
Traditional drug manufacturing is a time-consuming process. Active pharmaceutical ingredients are synthesized in a chemical manufacturing plant and then shipped to another site, where they are converted into giant batches ...
Other
Mar 12, 2012
0
0
